Skip to main content
Top
Published in: Current Cardiovascular Imaging Reports 5/2010

Open Access 01-10-2010

Angioscopic Evaluation of Neointimal Coverage of Coronary Stents

Authors: Yasumi Uchida, Yasuto Uchida

Published in: Current Cardiovascular Imaging Reports | Issue 5/2010

Login to get access

Abstract

Drug-eluting stents (DES) reduce coronary restenosis significantly; however, late stent thrombosis (LST) occurs, which requires long-term antiplatelet therapy. Angioscopic grading of neointimal coverage of coronary stent struts was established, and it was revealed that neointimal formation is incomplete and prevalence of LST is higher in DES when compared to bare-metal stents. It was also observed that the neointima is thicker and LST is less frequent in paclitaxel-eluting and zotarolimus-eluting stents than in sirolimus-eluting stents. Many new stents were devised and they are now under experimental or clinical investigations to overcome the shortcomings of the stents that have been employed clinically. Endothelial cells are highly anti-thrombotic. Neo-endothelial cell damage is considered to be caused by friction between the cells and stent struts due to the thin neointima between them which might act as a cushion. Therefore, development of a DES that causes an appropriate thickness (around 100 μm) of the neointima is a potential option with which to prevent neo-endothelial cell damage and consequent LST while preventing restenosis.
Literature
1.
go back to reference Inoue T, Node K: Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009, 73:615–621.CrossRefPubMed Inoue T, Node K: Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009, 73:615–621.CrossRefPubMed
2.
go back to reference Uchida Y: Coronary Angioscopy. Armonk, NY: Futura Publishing Company; 2001:83–91. Uchida Y: Coronary Angioscopy. Armonk, NY: Futura Publishing Company; 2001:83–91.
3.
go back to reference • Higo T, Ueda Y, Oyabu J, et al.: Atherosclerotic and thrombogenic neointima formed over SES. JACC Cardiovasc Imaging 2009, 2:616–624. The authors reported that yellow portions in the stented lesion are more thrombogenic than white portions in chronic phase.CrossRefPubMed • Higo T, Ueda Y, Oyabu J, et al.: Atherosclerotic and thrombogenic neointima formed over SES. JACC Cardiovasc Imaging 2009, 2:616–624. The authors reported that yellow portions in the stented lesion are more thrombogenic than white portions in chronic phase.CrossRefPubMed
4.
go back to reference Oyabu J, Ueda Y, Ogasawara N, et al.: Angioscopic evaluation of neointimal coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006, 52:1168–1174.CrossRef Oyabu J, Ueda Y, Ogasawara N, et al.: Angioscopic evaluation of neointimal coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006, 52:1168–1174.CrossRef
5.
go back to reference Kotani J, Awata M, Nanto S, et al.: Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006, 47:2108–2111.CrossRefPubMed Kotani J, Awata M, Nanto S, et al.: Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006, 47:2108–2111.CrossRefPubMed
6.
go back to reference Tsujimoto T: Relationships between angioscopic images of coronary stents and neointimal thickness measured by OCT. Proceedings of the 20th Annual Meeting of the Japanese Cardioangioscopy Society. 2006:30. Tsujimoto T: Relationships between angioscopic images of coronary stents and neointimal thickness measured by OCT. Proceedings of the 20th Annual Meeting of the Japanese Cardioangioscopy Society. 2006:30.
7.
go back to reference Sakai S, Mizuno K, Yokoyama S, et al.: Morphologic changes in infarct-related plaque after coronary stent placement. J Am Coll Cardiol 2003, 42:1558–1565.CrossRefPubMed Sakai S, Mizuno K, Yokoyama S, et al.: Morphologic changes in infarct-related plaque after coronary stent placement. J Am Coll Cardiol 2003, 42:1558–1565.CrossRefPubMed
8.
go back to reference Oyabu J, Ueda Y, Ogasawara N, et al.: Angioscopic evaluation of neointimal coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006, 52:1168–1174.CrossRef Oyabu J, Ueda Y, Ogasawara N, et al.: Angioscopic evaluation of neointimal coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006, 52:1168–1174.CrossRef
9.
go back to reference Awata M, Kotani J, Uematsu M, et al.: Serial angioscopic evidence of incomplete neointimal coverage after SES implantation. Circulation 2007, 116:910–916.CrossRefPubMed Awata M, Kotani J, Uematsu M, et al.: Serial angioscopic evidence of incomplete neointimal coverage after SES implantation. Circulation 2007, 116:910–916.CrossRefPubMed
10.
go back to reference •• Awata M, Nanto S, Uematsu M, et al.: Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents. J Am Coll Cardiol 2008, 52:789–790. The authors demonstrated differences in neointimal coverage of stent struts and LST between ZES and SES.CrossRefPubMed •• Awata M, Nanto S, Uematsu M, et al.: Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents. J Am Coll Cardiol 2008, 52:789–790. The authors demonstrated differences in neointimal coverage of stent struts and LST between ZES and SES.CrossRefPubMed
11.
go back to reference Takayama T, Hiro T, Akabane M, et al.: Heterogenecity of coverage and color of neointima after drug-eluting stent implantation: observation by angioscopy and OCT. Circulation 2009, 120:S968. Takayama T, Hiro T, Akabane M, et al.: Heterogenecity of coverage and color of neointima after drug-eluting stent implantation: observation by angioscopy and OCT. Circulation 2009, 120:S968.
12.
go back to reference Awata M, Nanto S, Uematsu M, et al.: Heterogenous arterial healing in patients following paclitaxel-eluting stent implantation. J Am Coll Cardiol Intv 2009, 2:453–458. Awata M, Nanto S, Uematsu M, et al.: Heterogenous arterial healing in patients following paclitaxel-eluting stent implantation. J Am Coll Cardiol Intv 2009, 2:453–458.
13.
go back to reference Ishii N, Takayama T, Honye J, et al.: Investigation of neointimal coverage grading and yellow plaque grading in stent site after SES implantation—angioscopic finding. Circ J 2008, 72(Suppl 1):546. Ishii N, Takayama T, Honye J, et al.: Investigation of neointimal coverage grading and yellow plaque grading in stent site after SES implantation—angioscopic finding. Circ J 2008, 72(Suppl 1):546.
14.
go back to reference Suzuki Y, Ikeno F, Koizumi T, et al.: In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degree of in-stent neointima after stent implantation. JACC Cardiovasc Intv 2008, 1:168–173.CrossRef Suzuki Y, Ikeno F, Koizumi T, et al.: In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degree of in-stent neointima after stent implantation. JACC Cardiovasc Intv 2008, 1:168–173.CrossRef
15.
go back to reference Miyoshi N, Shite J, Shnke T, et al.: Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure. Circ J 2010, In press. Miyoshi N, Shite J, Shnke T, et al.: Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure. Circ J 2010, In press.
16.
go back to reference Sera F, Awata M, Uematsu M, et al.: Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after SES implantation assessed by angioscopy. J Am Coll Cardiol Intv 2009, 2:989–994. Sera F, Awata M, Uematsu M, et al.: Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after SES implantation assessed by angioscopy. J Am Coll Cardiol Intv 2009, 2:989–994.
17.
go back to reference Chieffo A, Foglieni C, Nodari RL, et al.: Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol 2009, 104:1660–1667.CrossRefPubMed Chieffo A, Foglieni C, Nodari RL, et al.: Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol 2009, 104:1660–1667.CrossRefPubMed
18.
go back to reference Wilson GJ, Nakazawa G, Schwartz RS, et al.: Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009, 120:141–149.CrossRefPubMed Wilson GJ, Nakazawa G, Schwartz RS, et al.: Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009, 120:141–149.CrossRefPubMed
19.
go back to reference Kim JS, Kim JS, Kim TH, et al.: Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J 2010, 74:320–326.CrossRefPubMed Kim JS, Kim JS, Kim TH, et al.: Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J 2010, 74:320–326.CrossRefPubMed
20.
go back to reference Moore P, Barlis P, Spiro J, et al.: A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. JACC Cardiovasc Interv 2009, 2:437–444.CrossRefPubMed Moore P, Barlis P, Spiro J, et al.: A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. JACC Cardiovasc Interv 2009, 2:437–444.CrossRefPubMed
21.
go back to reference Higo T, Hirotani N, Ogasawara K, et al.: Sirolimus-eluting stent promotes formation of atherosclerotic neointima and yellow plaque at stented lesion: serial angioscopic study. Presented at the 81st Meeting of the American Heart Association. New Orleans, LA; November 2008. Higo T, Hirotani N, Ogasawara K, et al.: Sirolimus-eluting stent promotes formation of atherosclerotic neointima and yellow plaque at stented lesion: serial angioscopic study. Presented at the 81st Meeting of the American Heart Association. New Orleans, LA; November 2008.
22.
go back to reference Teramoto T, Ikeno F, Otake H, et al.: Intriguing peri-strut low-density area detected by optical coherence tomography after coronary stent deployment. Circ J 2010, In press. Teramoto T, Ikeno F, Otake H, et al.: Intriguing peri-strut low-density area detected by optical coherence tomography after coronary stent deployment. Circ J 2010, In press.
23.
go back to reference Fujimori Y, Morio H, Terasawa K, et al.: Angioscopic follow-up study on stented plaques in patients with acute myocardial infarction. Proceedings of the 13th Annual Meeting of Laser and Cardioangioscopy Society. 1999:28. Fujimori Y, Morio H, Terasawa K, et al.: Angioscopic follow-up study on stented plaques in patients with acute myocardial infarction. Proceedings of the 13th Annual Meeting of Laser and Cardioangioscopy Society. 1999:28.
24.
go back to reference Tsukahara R, Hou M, Muramatsu T: Characteristics of coronary plaques culprit for acute myocardial infarction in chronic stage [in Japanese]. Coronary 1998, 15:145–150. Tsukahara R, Hou M, Muramatsu T: Characteristics of coronary plaques culprit for acute myocardial infarction in chronic stage [in Japanese]. Coronary 1998, 15:145–150.
25.
go back to reference Takano M, Ohba T, Inami S, et al.: Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare-metal stents after 6-month implantation. Eur Heart J 2006, 27:2189–2195.CrossRefPubMed Takano M, Ohba T, Inami S, et al.: Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare-metal stents after 6-month implantation. Eur Heart J 2006, 27:2189–2195.CrossRefPubMed
26.
go back to reference Uchida Y, Uchida Y, Fujimori Y: Endothelial cells covering coronary stents are frequently damaged. Circulation 2006, 114 (Suppl II):591. Uchida Y, Uchida Y, Fujimori Y: Endothelial cells covering coronary stents are frequently damaged. Circulation 2006, 114 (Suppl II):591.
27.
go back to reference Uchida Y, Nakamura F, Tomaru T: Observation of atherosclerotic lesions by an intravascular microscope in patients with arteriosclerosis obliterance. Am Heart J 1995, 130:1114–1117.CrossRefPubMed Uchida Y, Nakamura F, Tomaru T: Observation of atherosclerotic lesions by an intravascular microscope in patients with arteriosclerosis obliterance. Am Heart J 1995, 130:1114–1117.CrossRefPubMed
28.
go back to reference Jandt E, Mutschke O, Mahboobi S, et al.: Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model. Vascul Pharmacol 2010, 52:55–62.CrossRefPubMed Jandt E, Mutschke O, Mahboobi S, et al.: Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model. Vascul Pharmacol 2010, 52:55–62.CrossRefPubMed
29.
go back to reference La Manna A, Capodanno D, Cara M, et al.: Optical coherence tomographic results at six-month follow-up evaluation of the CATANINA coronary stent system with nanothin polyzene-F surface modification (from the Assessment of the Latest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial). Am J Cardiol 2009, 103:1551–1555.CrossRefPubMed La Manna A, Capodanno D, Cara M, et al.: Optical coherence tomographic results at six-month follow-up evaluation of the CATANINA coronary stent system with nanothin polyzene-F surface modification (from the Assessment of the Latest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial). Am J Cardiol 2009, 103:1551–1555.CrossRefPubMed
30.
go back to reference Uchida Y, Uchida H, inventors: Therapeutic tool for vascular disease. US patent US7025981 B2. April 10, 2006. Uchida Y, Uchida H, inventors: Therapeutic tool for vascular disease. US patent US7025981 B2. April 10, 2006.
31.
go back to reference • Deuse T, Erben RG, Ikeno F, et al.: Introducing the first polymer-free leflunomide eluting stent. Atherosclerosis 2008, 200:126–134. The authors developed a polymer-free stent.CrossRefPubMed • Deuse T, Erben RG, Ikeno F, et al.: Introducing the first polymer-free leflunomide eluting stent. Atherosclerosis 2008, 200:126–134. The authors developed a polymer-free stent.CrossRefPubMed
Metadata
Title
Angioscopic Evaluation of Neointimal Coverage of Coronary Stents
Authors
Yasumi Uchida
Yasuto Uchida
Publication date
01-10-2010
Publisher
Current Science Inc.
Published in
Current Cardiovascular Imaging Reports / Issue 5/2010
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-010-9039-3

Other articles of this Issue 5/2010

Current Cardiovascular Imaging Reports 5/2010 Go to the issue